Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02855554 · ClinicalTrials.gov registry record · NA

Quantitative Cardiac Parametric Mapping

A NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT02855554 is a NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 240 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02855554, a NA study of Cardiomyopathy, Myocarditis, Ischemic Heart Disease, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ischemic heart disease, cardiomyopathies, and myocarditis.

Interventions

  • OTHER Cardiac Magnetic Resonance (CMR) imaging techniques

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2014-06-20
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT02855554

The ClinicalTrials.gov registry entry for NCT02855554 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiomyopathy, Myocarditis, Ischemic Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Magnetic Resonance (CMR) imaging techniques is the first listed.

NCT02855554 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT02855554 about?

NCT02855554 is a clinical study titled "Quantitative Cardiac Parametric Mapping". The overall goal of this project is to evaluate the clinical potential of fast quantitative myocardial tissue characterization using recently emerged Cardiac Magnetic Resonance Imaging (CMR) techniques to aid the diagnosis, treatment, and follow up of patients with myocardial diseases, such as ische...

What is the current status of trial NCT02855554?

This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2014-06-20. Estimated completion is 2026-12.

What conditions does trial NCT02855554 study?

This clinical trial studies the following conditions: Cardiomyopathy, Myocarditis, Ischemic Heart Disease.

What interventions are being tested in trial NCT02855554?

The interventions under investigation include: Cardiac Magnetic Resonance (CMR) imaging techniques (OTHER).

Who is sponsoring clinical trial NCT02855554?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02855554 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.